Research ArticleResearch

Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry

Anthony B. Ciavarella, Mansoor A. Khan, Abhay Gupta and Patrick J. Faustino
PDA Journal of Pharmaceutical Science and Technology November 2016, 70 (6) 523-532; DOI: https://doi.org/10.5731/pdajpst.2015.006411

Reference

  1. 1.↵
    1. Quinzler R.,
    2. Gasse C.,
    3. Schneider A.,
    4. Kaufmann-Kolle P.,
    5. Szecsenyi J.,
    6. Haefeli W. E.
    The frequency of inappropriate tablet splitting in primary care. Eur. J. Clin. Pharmacol. 2006, 62 (12), 1065–1073.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Elliott I.,
    2. Mayxay M.,
    3. Yeuichaixong S.,
    4. Lee S. J.,
    5. Newton P. N.
    The Practice and Clinical Implications of Tablet Splitting in International Health. Trop. Med. Int. Health 2014, 19 (7), 754–760.
    OpenUrl
  3. 3.↵
    1. Verrue C.,
    2. Mehuys E.,
    3. Boussery K.,
    4. Remon J. P.,
    5. Petrovic M.
    Tablet-splitting: A Common yet Not So Innocent Practice. J. Adv. Nurs. 2011, 67 (1), 26–32.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Berg C.,
    2. Ekedahl A.
    Dosages Involving Splitting Tablets: Common but Unnecessary? J. Pharm. Health Services Res. 2010, 1 (3), 137–141.
    OpenUrl
  5. 5.↵
    1. Dormuth C. R.,
    2. Schneeweiss S.,
    3. Brookhart A. M.,
    4. Carney G.,
    5. Bassett K.,
    6. Adams S.,
    7. Wright J. M.
    Frequency and Predictors of Tablet Splitting in Statin Prescriptions: A Population-based Analysis. Open Med. 2008, 2 (3), e74–e82.
    OpenUrlPubMed
  6. 6.↵
    1. Rosenberg J. M.,
    2. Nathan J.,
    3. Plakogiannis F.
    Weight Variability of Pharmacist-dispensed Split Tablets. Am. J. Pharm. Assoc. (Wash.) 2002, 42 (2), 200–205.
    OpenUrl
  7. 7.↵
    1. Volpe D. A.,
    2. Gupta A.,
    3. Ciavarella A. B.,
    4. Faustino P. J.,
    5. Sayeed V. A.,
    6. Khan M. A.
    Comparison of the stability of split and intact gabapentin tablets. Int. J. Pharm. 2008, 350 (1-2), 65–69.
    OpenUrlPubMed
  8. 8.↵
    1. Freeman M. K.,
    2. White W.,
    3. Iranikhah M.
    Tablet Splitting: A Review of Weight and Content Uniformity. Consult. Pharm. 2012, 27 (5), 341–352.
    OpenUrlPubMed
  9. 9.↵
    1. Hill S. W.,
    2. Varker A. S.,
    3. Karlage K.,
    4. Myrdal P. B.
    Analysis of Drug Content and Weight Uniformity for Half-Tablets of 6 Commonly Split Medications. J. Manage. Care Pharm. 2009, 15 (3), 253–261.
    OpenUrl
  10. 10.↵
    1. Teng J.,
    2. Song C. K.,
    3. Williams R. L.,
    4. Polli J. E.
    Lack of Medication Dose Uniformity in Commonly Split Tablets. Am. J. Pharm. Assoc. (Wash.) 2001, 42 (2), 195–199.
    OpenUrl
  11. 11.↵
    1. Shah R. B.,
    2. Collier J. S.,
    3. Sayeed V. A.,
    4. Bryant A.,
    5. Habib M. J.,
    6. Khan M. A.
    Tablet Splitting of a Narrow Therapeutic Index Drug: A Case with Levothyroxine Sodium. AAPS PharmSciTech 2010, 11 (3), 1359–1367.
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Zhao N.,
    2. Zidan A.,
    3. Tawakkul M.,
    4. Sayeed V. A.,
    5. Khan M.
    Tablet Splitting: Product Quality Assessment of Metoprolol Succinate Extended Release Tablets. Int. J. Pharm. 2010, 401 (1-2), 25–31.
    OpenUrlPubMed
  13. 13.↵
    Guidance for Industry. Tablet Scoring: Nomenclature, Labeling, and Data for Evaluation; U.S. Food and Drug Administration: Silver Spring, MD, 2013.
  14. 14.↵
    <905> Uniformity of Dosage Units. In United States Pharmacopeia, 2011.
  15. 15.↵
    1. Zaid A. N.,
    2. Abu Ghosh A.
    Compliance of Scored Tablet Halves Produced by Palestinian Pharmaceutical Companies with the New European Pharmacopoeia Requirements. Arch. Pharm. Res. 2011, 34 (7), 1183–1189.
    OpenUrlPubMed
  16. 16.↵
    1. Margiocco M. L.,
    2. Warren J. F.,
    3. Borgarelli M. F.,
    4. Kukanich B.
    Analysis of Weight Uniformity, Content Uniformity and 30-day Stability in Halves and Quarters of Routinely Prescribed Cardiovascular Medications. J. Vet. Cardiol. 2009, 11 (1), 31–39.
    OpenUrlPubMed
  17. 17.↵
    1. Gupta A.,
    2. Hunt R. L.,
    3. Khan M. A.
    Influence of Tablet Characteristics on Weight Variability and Weight Loss in Split Tablets. Am. J. Health-Syst. Pharm. 2008, 65 (24), 2326–2328.
    OpenUrlFREE Full Text
  18. 18.↵
    1. Huynh-Ba K.
    1. Sayeed V. A.,
    2. Gupta A.,
    3. Khan M. A.
    Stability of Split Tablets. In Pharmaceutical Stability Testing to Support Global Markets, Huynh-Ba K., Ed.; Springer: New York, 2010; pp 153–160.
  19. 19.↵
    1. Ciavarella A. B.,
    2. Gupta A.,
    3. Sayeed V. A.,
    4. Khan M. A.,
    5. Faustino P. J.
    Development and Application of a Validated HPLC Method for the Determination of Gabapentin and Its Major Degradation Impurity in Drug Products. J. Pharm. Biomed. Anal. 2007, 43 (5), 1647–1653.
    OpenUrlPubMed
  20. 20.↵
    ICH Harmonized Tripartite Guideline: Validation of Analytical Procedures: Text and Methodology Q2(R1), 2005.
  21. 21.↵
    1. Müller B.,
    2. Kublik H.
    Dosiergenauigkeit bei Tabletten mit Bruchrille? Deutsche Apotheker Zeitung-Stuttgart 1993, 133, 15.
    OpenUrl
  22. 22.↵
    1. Spang R.
    Teilbarkeit von Tabletten und Filmdragees. Pharm. Acta Helv. 1982, 57 (4), 99–111.
    OpenUrlPubMed
  23. 23.↵
    1. McDevitt J. T.,
    2. Gurst A. H.,
    3. Chen Y.
    Accuracy of Tablet Splitting. Pharmacotherapy 1998, 18 (1), 193–197.
    OpenUrlPubMedWeb of Science
  24. 24.↵
    1. Polli J. E.,
    2. Kim S.,
    3. Martin B. R.
    Weight Uniformity of Split Tablets Required by a Veterans Affairs Policy. J. Manage. Care Pharm. 2002, 9 (5), 401–407.
    OpenUrl
  25. 25.↵
    1. van Santen E.,
    2. Barends D. M.,
    3. Frijlink H. W.
    Breaking of Scored Tablets: A Review. Eur. J. Pharm. Biopharm. 2002, 53 (2), 139–145.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Duncan M. C.,
    2. Castle S. S.,
    3. Streetman D. S.
    Effect of Tablet Splitting on Serum Cholesterol Concentrations. Ann. Pharmacother. 2002, 36 (2), 205–209.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Gee M.,
    2. Hasson N. K.,
    3. Hahn T.,
    4. Ryono R.
    Effects of a Tablet-splitting Program in Patients Taking HMG-CoA Reductase Inhibitors: Analysis of Clinical Effects, Patient Satisfaction, Compliance, and Cost Avoidance. J. Manage. Care Pharm. 2001, 8 (6), 453–458.
    OpenUrl
  28. 28.↵
    1. Parra D.,
    2. Beckey N. P.,
    3. Raval H. S.,
    4. Schnacky K. R.,
    5. Calabrese V.,
    6. Coakley R. W.,
    7. Goodhope R.
    C; Veterans Integrated Service Network 8 Pharmacy Benefits Management Utilization Committee. Effect of Splitting Simvastatin Tablets for Control of Low-density Lipoprotein Cholesterol. Am. J. Cardiol. 2005, 95 (12), 1481–1483.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Rindone J.
    Evaluation of Tablet-splitting in Patients Taking Lisinopril for Hypertension. J. Clin. Outcomes Manage. 2000, 7 (4), 22–30.
    OpenUrl
  30. 30.↵
    1. Weissman E. M.,
    2. Dellenbaugh C.
    Impact of Splitting Risperidone Tablets on Medication Adherence and on Clinical Outcomes for Patients with Schizophrenia. Psychiatric Services 2007, 58 (2), 201–206.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In This Issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Dose Uniformity of Scored and Unscored Tablets: Application of the FDA Tablet Scoring Guidance for Industry
Anthony B. Ciavarella, Mansoor A. Khan, Abhay Gupta, Patrick J. Faustino
PDA Journal of Pharmaceutical Science and Technology Nov 2016, 70 (6) 523-532; DOI: 10.5731/pdajpst.2015.006411
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords